JP2021530498A5 - - Google Patents
Info
- Publication number
- JP2021530498A5 JP2021530498A5 JP2021500858A JP2021500858A JP2021530498A5 JP 2021530498 A5 JP2021530498 A5 JP 2021530498A5 JP 2021500858 A JP2021500858 A JP 2021500858A JP 2021500858 A JP2021500858 A JP 2021500858A JP 2021530498 A5 JP2021530498 A5 JP 2021530498A5
- Authority
- JP
- Japan
- Prior art keywords
- domain
- igg1
- domain monomer
- monomer
- polypeptide
- Prior art date
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862696759P | 2018-07-11 | 2018-07-11 | |
| US62/696,759 | 2018-07-11 | ||
| US201862733036P | 2018-09-18 | 2018-09-18 | |
| US62/733,036 | 2018-09-18 | ||
| US201862744067P | 2018-10-10 | 2018-10-10 | |
| US62/744,067 | 2018-10-10 | ||
| PCT/US2019/041468 WO2020014526A2 (en) | 2018-07-11 | 2019-07-11 | Compositions and methods related to engineered fc-antigen binding domain constructs targeted to cd38 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021530498A JP2021530498A (ja) | 2021-11-11 |
| JPWO2020014526A5 JPWO2020014526A5 (https=) | 2022-07-15 |
| JP2021530498A5 true JP2021530498A5 (https=) | 2022-07-15 |
Family
ID=69141927
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021500858A Withdrawn JP2021530498A (ja) | 2018-07-11 | 2019-07-11 | ＣＤ３８を標的とする改変Ｆｃ抗原結合ドメイン構築体に関する組成物および方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20210269546A1 (https=) |
| EP (1) | EP3820516A4 (https=) |
| JP (1) | JP2021530498A (https=) |
| KR (1) | KR20210044218A (https=) |
| CN (1) | CN113194990A (https=) |
| AU (1) | AU2019299973A1 (https=) |
| BR (1) | BR112021000416A2 (https=) |
| CA (1) | CA3106142A1 (https=) |
| IL (1) | IL280046A (https=) |
| MX (1) | MX2021000307A (https=) |
| WO (1) | WO2020014526A2 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JOP20210044A1 (ar) * | 2010-12-30 | 2017-06-16 | Takeda Pharmaceuticals Co | الأجسام المضادة لـ cd38 |
| CN118591388A (zh) * | 2021-09-29 | 2024-09-03 | 摩德斯医疗股份有限公司 | 抗原结合多肽、抗原结合多肽复合物及其使用方法 |
| CN115873127B (zh) * | 2021-11-26 | 2026-04-10 | 深圳科兴药业有限公司 | 重组长效人生长激素融合蛋白及其制备方法和用途 |
| EP4448585A4 (en) * | 2021-12-17 | 2026-02-25 | Modex Therapeutics Inc | ANTIGEN-BINDING POLYPEPTIDE COMPLEXES CONTAINING EXTRACELLULAR DOMAINS OF TNFSF LIGANDS |
| WO2025229158A1 (en) * | 2024-05-01 | 2025-11-06 | Commit Biologics Aps | Antibodies and antibody constructs against cd38 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20140242081A1 (en) * | 2011-07-18 | 2014-08-28 | Micromet Ag | Dosing regimens for treatment of cea-expressing cancers |
| EP2748197A2 (en) * | 2011-08-26 | 2014-07-02 | Merrimack Pharmaceuticals, Inc. | Tandem fc bispecific antibodies |
| KR20200024345A (ko) * | 2013-01-10 | 2020-03-06 | 젠맵 비. 브이 | 인간 IgG1 Fc 영역 변이체 및 그의 용도 |
| AU2015358615B2 (en) * | 2014-12-04 | 2021-08-05 | Janssen Biotech, Inc. | Anti-CD38 antibodies for treatment of acute myeloid leukemia |
| CA2994746A1 (en) * | 2015-08-11 | 2017-02-16 | Cellectis | Cells for immunotherapy engineered for targeting cd38 antigen and for cd38 gene inactivation |
| WO2017151971A2 (en) * | 2016-03-02 | 2017-09-08 | Momenta Pharmaceuticals, Inc. | METHODS RELATED TO ENGINEERED Fc CONSTRUCTS |
| BR112018074056A2 (pt) * | 2016-05-23 | 2019-03-06 | Momenta Pharmaceuticals, Inc. | composições e métodos relacionados a construtos de fc manipulados |
| CA3043251A1 (en) * | 2016-12-09 | 2018-06-14 | Gliknik Inc. | Methods of treating inflammatory disorders with multivalent fc compounds |
-
2019
- 2019-07-11 WO PCT/US2019/041468 patent/WO2020014526A2/en not_active Ceased
- 2019-07-11 CA CA3106142A patent/CA3106142A1/en active Pending
- 2019-07-11 AU AU2019299973A patent/AU2019299973A1/en not_active Abandoned
- 2019-07-11 BR BR112021000416-5A patent/BR112021000416A2/pt not_active IP Right Cessation
- 2019-07-11 US US17/259,491 patent/US20210269546A1/en not_active Abandoned
- 2019-07-11 JP JP2021500858A patent/JP2021530498A/ja not_active Withdrawn
- 2019-07-11 CN CN201980059584.0A patent/CN113194990A/zh active Pending
- 2019-07-11 MX MX2021000307A patent/MX2021000307A/es unknown
- 2019-07-11 KR KR1020217004249A patent/KR20210044218A/ko not_active Ceased
- 2019-07-11 EP EP19833127.4A patent/EP3820516A4/en not_active Withdrawn
-
2021
- 2021-01-10 IL IL280046A patent/IL280046A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021530498A5 (https=) | ||
| JP2021532085A5 (https=) | ||
| RU2019124709A (ru) | КОМПОЗИЦИИ И СПОСОБЫ, СВЯЗАННЫЕ СО СКОНСТРУИРОВАННЫМИ КОНСТРУКЦИЯМИ НА ОСНОВЕ Fc-АНТИГЕНСВЯЗЫВАЮЩЕГО ДОМЕНА | |
| JP2020514301A5 (https=) | ||
| ES2527961T3 (es) | Anticuerpos monoclonales humanos para CD70 | |
| ES2547463T3 (es) | Moléculas de unión a ILT3 y usos de las mismas | |
| HRP20201517T1 (hr) | Anti-cd3 protutijela, anti-cd123 protutijela i bispecifična protutijela koja se specifično vežu na cd3 i/ili cd123 | |
| JP2020508655A5 (https=) | ||
| Wu et al. | Molecular construction and optimization of anti-human IL-1α/β dual variable domain immunoglobulin (DVD-IgTM) molecules | |
| JP2021531268A5 (https=) | ||
| RU2007139953A (ru) | Антитела к ccr5 и их применение | |
| DE602004021702D1 (de) | Humanisierter antikörper gegen cd4 mit immunsuppressiven merkmalen | |
| RU2011148913A (ru) | Иммуноглобулин с двумя вариабельными доменами и его применение | |
| JP2017504578A5 (https=) | ||
| JP2021530989A5 (https=) | ||
| DE50210328D1 (de) | Bispezifisches anti-cd28 antikörper-molekül | |
| RU2018129878A (ru) | Иммуноглобулин с тандемными fab-фрагментами и варианты его применения | |
| DK1697421T3 (da) | Bispecifikke antistoffer | |
| RU2016138347A (ru) | Трифункциональная антигенсвязывающая молекула | |
| NZ588713A (en) | Antibodies to receptor of advanced glycation end products (rage) and uses thereof | |
| JP2021531756A5 (https=) | ||
| WO2003054020A3 (en) | Human antibodies against human glycoprotein vi and their use | |
| FI4031569T3 (fi) | Kantasolutekijän vasta-aineet ja niiden käyttömenetelmät | |
| JPWO2020014413A5 (https=) | ||
| JPWO2020014526A5 (https=) |